US2006083777A1PendingUtilityA1
Treatment of acne
Est. expiryApr 23, 2021(expired)· nominal 20-yr term from priority
A61K 33/243A61K 33/242A61L 15/46A61L 31/082A61L 29/10A61L 2300/63A61L 27/30A61K 9/70A61K 9/14A61L 2300/104A61L 17/145A61L 2300/404A61K 33/38A61K 9/0014
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the use of one or more antimicrobial metals selected from silver, gold, platinum, and palladium but most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of a acne. The nanocrystalline antimicrobial metal of choice may be used in the form of a nanocrystalline coating of one or more antimicrobial metals, a nanocrystalline powder of one or more antimicrobial metals, or a solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial metals.
Claims
exact text as granted — not AI-modified1 . A method of treating acne conditions, which comprises:
contacting acne problem area of a patient, with a therapeutically effective amount of one or more antimicrobial metals in a crystalline form to provide a localize antimicrobial and anti-inflammatory effect.
2 - 12 . (canceled)
13 . A method of treating acne conditions, the method comprising:
contacting an area of a patient having acne with a therapeutically effective amount of one or more antimicrobial metals in a crystalline form to provide a localize antimicrobial and anti-inflammatory effect.
14 . The method of claim 13 , wherein the one or more antimicrobial metals are characterized by sufficient atomic disorder, when in contact with an alcohol or water-based electrolyte, at least one of the one or more antimicrobial metals releases atoms, ions, molecules, or clusters of at least one antimicrobial metal at a concentration sufficient to provide a localized antimicrobial and anti-inflammatory effect.
15 . The method of claim 13 , wherein the one or more antimicrobial metals comprise nanocrystalline silver.
16 . The method of claim 15 , wherein the nanocrystalline silver is formed with sufficient atomic disorder such that, in contact with an alcohol or water based electrolyte, the silver releases ions, atoms, molecules or clusters of the silver on a sustainable basis.
17 . The method of claim 13 , wherein the one or more antimicrobial metals are provided as a coating on, or filler in, a dressing.
18 . The method of claim 17 , wherein the coating is provided on a dressing.
19 . The method of claim 18 , wherein the coating is 150-3000 nm thick.
20 . The method of claim 19 , wherein the dressing fixed in place with an occlusive or semi-occlusive layer which maintains the dressing in a moist condition.
21 . The method of claim 21 , wherein the occlusive or semi-occlusive layer is an adhesive tape or film.
22 . The method of claim 13 , wherein the one or more antimicrobial metals are in a pharmaceutical composition with one or more pharmaceutically and dermatogically acceptable carriers, diluents, or excipients suitable for topical application.
23 . The method of claim 22 , wherein the pharmaceutical composition includes a nanocrystalline powder of one or more antimicrobial metals.
24 . The method of claim 22 , wherein the pharmaceutical composition includes a solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial metals.
25 . The method of claim 22 , wherein the pharmaceutical composition is in at least one form selected from the group consisting of gels, creams and lotions.
26 . The method of claim 25 , wherein the pharmaceutical composition contains the one or more antimicrobial metals in an amount of 0.01-5% by weight.
27 . The method of claim 25 , wherein the pharmaceutical composition is in the form of a liquid containing 0.001-1% by weight of the antimicrobial metal.
28 . A method of treating acne conditions, the method comprising:
contacting an area of a patient having acne with a therapeutically effective amount of at least one nanocrystalline metals to provide a localize antimicrobial and anti-inflammatory effect.Join the waitlist — get patent alerts
Track US2006083777A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.